Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (20192)	4/27/2004 1:03:58 PM
From: GARY P GROBBEL	Respond to of 120405

OISI trading today...45,000 at 1.20...another very solid play..good entry point: B: Ophthalmic Imaging Systems Reports Fiscal 2003 Annual Results; B: Ophthalmic Imaging Systems Reports Fiscal 2003 Annual Results; Company Record SACRAMENTO, Calif., Mar 15, 2004 (BUSINESS WIRE) -- Ophthalmic Imaging Systems ("OIS" or the "Company") (OTCBB:OISI) today reported its financial results for the year ended December 31, 2003. The Company's net revenues for fiscal 2003 were $9,945,000, an increase of 17% over net revenues of $8,466,000 for the previous fiscal year. The Company reported net earnings of $1,438,000 or $0.13 per basic share and $0.12 per diluted share, for fiscal 2003 compared with net income of $565,000, or $0.07 per basic and per diluted share, for fiscal 2002, an increase of 155%. The fiscal 2003 results included a gain of $449,000, or $0.04 per share, from income tax benefits associated with net operating loss carryover. Without this gain, the Company would have reported a net income of $0.09 per basic share and $0.08 per diluted share for fiscal 2003. "We are extremely pleased with the Company's performance during the last year," commented Gil Allon, CEO of Ophthalmic Imaging Systems. "These results reflect the success of our WinStation line of products, which offer ultra-high resolution digital imaging solutions, in the ophthalmic market. In addition, the alliance we entered into with NextGen Healthcare Information Systems, Inc. in 2003 diversified our product line and enabled us to participate in the rapidly growing market of Electronic Medical Records (EMR)." Jonathan Adereth, Chairman of Ophthalmic Imaging Systems, stated, "In 2003, we saw a major improvement in our operational and financial performance; we increased our revenues, operating and profit margins, and earnings per share as well as strengthened our balance sheet. For the previous three years we have successfully managed our business to improve our operating margins while increasing our revenues." Ophthalmic Imaging Systems, a majority-owned subsidiary of MediVision Medical Imaging Ltd., is a leading provider of ophthalmic digital imaging systems. The Company designs, develops, manufactures and markets digital imaging systems for the eye care market. With over eighteen years in the ophthalmic imaging business, the Company has consistently introduced new, innovative technology. The Company, together with MediVision, co-market and support their products worldwide through an extensive network of dealers, distributors, and direct representatives.